EGFR and non-small cell lung carcinoma: Furthermore, in a study conducted by the West Japan Oncology Group 6911L, the combination of gefitinib and concurrent thoracic radiotherapy was explored in 27 patients with unresectable locally advanced NSCLC harboring EGFR mutations.